Validation pour Ingenuity236

vers la météo de la validation par utilisateur

Ingenuity236

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 14 - PMID ?

In Hela cells treated with cycloheximide and with zVAD FMK and overproducing SP NODE protein , agonist anti SP Apo 1 [NODE] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a NODE protein protein binding site .

name="reponse" value="NA"> Non annotée
name="reponse" value="JSP"> Je ne sais pas
name="reponse" value="INS"> Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

<?php echo $Com ; ?>

name="reponse" value="A0">Analyse 0

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A1">Analyse 1

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A2">Analyse 2

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A3">Analyse 3

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A4">Analyse 4

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A5">Analyse 5

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                                                                                        +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A6">Analyse 6

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                          +------------------------OBJ:V-N-----------------------+                                                    |                                                                              +----------------OBJ:V-N----------------+   
           |                                                          |          +-------------MOD_ATT:N-ADJ------------+    |                                                    +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+          |       +---------MOD_ATT:N-ADJ--------+    |                           +--------SUBJ:V-N--------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          |       |                 +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+--COMP:N-N(in)-+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       |                 |      +MOD_A+MOD_+         |        +MOD_ATT:+         +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |                 |      |     |    |         |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,Apo)
MOD_ATT:N-ADJ (__SP__,__SP__)
MOD_ATT:N-ADJ (__SP__,__NODE__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,antibody)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A7">Analyse 7

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A8">Analyse 8

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A9">Analyse 9

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A10">Analyse 10

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A11">Analyse 11

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A12">Analyse 12

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A13">Analyse 13

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A14">Analyse 14

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A15">Analyse 15

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A16">Analyse 16

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A17">Analyse 17

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A18">Analyse 18

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A19">Analyse 19

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A20">Analyse 20

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A21">Analyse 21

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A22">Analyse 22

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A23">Analyse 23

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A24">Analyse 24

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A25">Analyse 25

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A26">Analyse 26

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A27">Analyse 27

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A28">Analyse 28

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A29">Analyse 29

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +-------------------------SUBJ:V-N-------------------------+----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
SUBJ:V-N (overproduce,cell)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A30">Analyse 30

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A31">Analyse 31

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A32">Analyse 32

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A33">Analyse 33

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A34">Analyse 34

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A35">Analyse 35

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A36">Analyse 36

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A37">Analyse 37

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A38">Analyse 38

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A39">Analyse 39

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A40">Analyse 40

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A41">Analyse 41

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A42">Analyse 42

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A43">Analyse 43

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A44">Analyse 44

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                                                                                        |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A45">Analyse 45

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                                                                                        +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A46">Analyse 46

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                                                                                        |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                                      +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A47">Analyse 47

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A48">Analyse 48

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A49">Analyse 49

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A50">Analyse 50

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                                          +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A51">Analyse 51

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A52">Analyse 52

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A53">Analyse 53

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A54">Analyse 54

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A55">Analyse 55

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A56">Analyse 56

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +----------OBJ:V-N---------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A57">Analyse 57

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A58">Analyse 58

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A59">Analyse 59

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A60">Analyse 60

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A61">Analyse 61

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                                                                                                                         +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A62">Analyse 62

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A63">Analyse 63

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A64">Analyse 64

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A65">Analyse 65

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A66">Analyse 66

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+                              |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +---MOD_ATT:N-ADJ--+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A67">Analyse 67

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A68">Analyse 68

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A69">Analyse 69

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A70">Analyse 70

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +-------MOD_ATT:N-ADJ------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A71">Analyse 71

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A72">Analyse 72

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                         |            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A73">Analyse 73

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A74">Analyse 74

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A75">Analyse 75

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A76">Analyse 76

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A77">Analyse 77

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A78">Analyse 78

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A79">Analyse 79

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A80">Analyse 80

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A81">Analyse 81

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A82">Analyse 82

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A83">Analyse 83

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A84">Analyse 84

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A85">Analyse 85

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A86">Analyse 86

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A87">Analyse 87

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A88">Analyse 88

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A89">Analyse 89

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +-------MOD_ATT:N-ADJ------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A90">Analyse 90

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A91">Analyse 91

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A92">Analyse 92

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                                      |                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A93">Analyse 93

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A94">Analyse 94

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A95">Analyse 95

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
                                                                                                                        |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A96">Analyse 96

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A97">Analyse 97

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A98">Analyse 98

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A99">Analyse 99

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      |                             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A100">Analyse 100

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                                                               |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A101">Analyse 101

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A102">Analyse 102

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A103">Analyse 103

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A104">Analyse 104

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +---MOD_ATT:N-ADJ--+       |                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A105">Analyse 105

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A106">Analyse 106

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A107">Analyse 107

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A108">Analyse 108

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A109">Analyse 109

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +-------MOD_ATT:N-ADJ------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A110">Analyse 110

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                                                       +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A111">Analyse 111

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                                                       +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A112">Analyse 112

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A113">Analyse 113

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A114">Analyse 114

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A115">Analyse 115

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A116">Analyse 116

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A117">Analyse 117

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A118">Analyse 118

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A119">Analyse 119

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A120">Analyse 120

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A121">Analyse 121

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A122">Analyse 122

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A123">Analyse 123

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A124">Analyse 124

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A125">Analyse 125

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A126">Analyse 126

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A127">Analyse 127

      +---------------------------------------------------COMP:V-N(In)--------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +--------------------------------------------------SUBJ:V-N--------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A128">Analyse 128

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A129">Analyse 129

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A130">Analyse 130

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A131">Analyse 131

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A132">Analyse 132

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A133">Analyse 133

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A134">Analyse 134

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A135">Analyse 135

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A136">Analyse 136

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A137">Analyse 137

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                                                                                        +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A138">Analyse 138

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A139">Analyse 139

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                                                               |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A140">Analyse 140

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A141">Analyse 141

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A142">Analyse 142

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A143">Analyse 143

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A144">Analyse 144

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                                              |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                                              |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                                              |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A145">Analyse 145

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A146">Analyse 146

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            +-----SUBJ:V-N-----+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +--OBJ:V-N-+       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A147">Analyse 147

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A148">Analyse 148

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A149">Analyse 149

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------------COMP:V_PASS-N(with)---------------------+                                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A150">Analyse 150

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +---MOD_ATT:N-ADJ--+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A151">Analyse 151

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A152">Analyse 152

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------------COMP:V_PASS-N(with)---------------------+                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A153">Analyse 153

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                                              |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                                              |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                                              |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A154">Analyse 154

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A155">Analyse 155

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A156">Analyse 156

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A157">Analyse 157

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +----------OBJ:V-N---------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A158">Analyse 158

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A159">Analyse 159

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A160">Analyse 160

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +-------MOD_ATT:N-ADJ------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A161">Analyse 161

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A162">Analyse 162

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A163">Analyse 163

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A164">Analyse 164

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
                                                         |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                       |                         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A165">Analyse 165

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A166">Analyse 166

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A167">Analyse 167

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A168">Analyse 168

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A169">Analyse 169

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A170">Analyse 170

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A171">Analyse 171

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A172">Analyse 172

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A173">Analyse 173

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A174">Analyse 174

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A175">Analyse 175

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A176">Analyse 176

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A177">Analyse 177

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A178">Analyse 178

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A179">Analyse 179

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A180">Analyse 180

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A181">Analyse 181

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A182">Analyse 182

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A183">Analyse 183

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A184">Analyse 184

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A185">Analyse 185

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A186">Analyse 186

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A187">Analyse 187

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A188">Analyse 188

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A189">Analyse 189

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A190">Analyse 190

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A191">Analyse 191

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                       |                         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A192">Analyse 192

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A193">Analyse 193

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        |                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A194">Analyse 194

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A195">Analyse 195

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A196">Analyse 196

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A197">Analyse 197

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A198">Analyse 198

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                     |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                     |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                     |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A199">Analyse 199

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A200">Analyse 200

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A201">Analyse 201

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A202">Analyse 202

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                      |                      |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A203">Analyse 203

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+                      +----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A204">Analyse 204

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A205">Analyse 205

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                                          +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                                          |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                         +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                         |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A206">Analyse 206

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A207">Analyse 207

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A208">Analyse 208

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                +---------------------OBJ:V-N--------------------+                                              +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A209">Analyse 209

                                                         +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A210">Analyse 210

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
                                                         |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
                                                         |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
                                                         |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
                                                         |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                         |                       |                         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A211">Analyse 211

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
                                                         +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A212">Analyse 212

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
                                                         |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                               |                 |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A213">Analyse 213

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A214">Analyse 214

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A215">Analyse 215

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A216">Analyse 216

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A217">Analyse 217

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A218">Analyse 218

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A219">Analyse 219

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A220">Analyse 220

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A221">Analyse 221

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A222">Analyse 222

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A223">Analyse 223

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A224">Analyse 224

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A225">Analyse 225

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A226">Analyse 226

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A227">Analyse 227

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A228">Analyse 228

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A229">Analyse 229

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A230">Analyse 230

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A231">Analyse 231

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    |   +------MOD_ATT:N-N------+               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A232">Analyse 232

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A233">Analyse 233

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A234">Analyse 234

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A235">Analyse 235

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    |   +------MOD_ATT:N-N------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A236">Analyse 236

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A237">Analyse 237

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A238">Analyse 238

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A239">Analyse 239

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A240">Analyse 240

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +-------MOD_ATT:N-ADJ-------+               |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A241">Analyse 241

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A242">Analyse 242

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +---MOD_ATT:N-ADJ--+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A243">Analyse 243

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A244">Analyse 244

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A245">Analyse 245

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A246">Analyse 246

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A247">Analyse 247

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A248">Analyse 248

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A249">Analyse 249

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A250">Analyse 250

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +-----SUBJ:V-N-----+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +--OBJ:V-N-+       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A251">Analyse 251

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A252">Analyse 252

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A253">Analyse 253

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A254">Analyse 254

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A255">Analyse 255

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+                              |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A256">Analyse 256

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A257">Analyse 257

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A258">Analyse 258

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A259">Analyse 259

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A260">Analyse 260

                                                                                                                                                         +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +----MOD_ATT:N-N---+       |                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A261">Analyse 261

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A262">Analyse 262

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A263">Analyse 263

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A264">Analyse 264

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A265">Analyse 265

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |      +------------------------------COMP:V_PASS-N(with)-----------------------------+         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |                                                   +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A266">Analyse 266

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A267">Analyse 267

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A268">Analyse 268

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A269">Analyse 269

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A270">Analyse 270

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A271">Analyse 271

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A272">Analyse 272

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A273">Analyse 273

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A274">Analyse 274

                                                         +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A275">Analyse 275

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A276">Analyse 276

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A277">Analyse 277

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A278">Analyse 278

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A279">Analyse 279

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A280">Analyse 280

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A281">Analyse 281

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A282">Analyse 282

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A283">Analyse 283

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A284">Analyse 284

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A285">Analyse 285

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A286">Analyse 286

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A287">Analyse 287

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A288">Analyse 288

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A289">Analyse 289

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A290">Analyse 290

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A291">Analyse 291

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A292">Analyse 292

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A293">Analyse 293

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A294">Analyse 294

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A295">Analyse 295

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A296">Analyse 296

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A297">Analyse 297

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A298">Analyse 298

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                                             |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A299">Analyse 299

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                                              |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                                              |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                                              |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A300">Analyse 300

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A301">Analyse 301

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A302">Analyse 302

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                             |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A303">Analyse 303

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                                             |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A304">Analyse 304

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +-------MOD_ATT:N-ADJ-------+               |                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A305">Analyse 305

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A306">Analyse 306

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A307">Analyse 307

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A308">Analyse 308

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A309">Analyse 309

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A310">Analyse 310

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A311">Analyse 311

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+-----COMP:V-N(In)-----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(In) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A312">Analyse 312

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A313">Analyse 313

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A314">Analyse 314

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A315">Analyse 315

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A316">Analyse 316

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A317">Analyse 317

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A318">Analyse 318

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A319">Analyse 319

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A320">Analyse 320

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A321">Analyse 321

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A322">Analyse 322

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                                                                                        |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A323">Analyse 323

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A324">Analyse 324

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                       |                         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |                       |                         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A325">Analyse 325

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A326">Analyse 326

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A327">Analyse 327

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A328">Analyse 328

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A329">Analyse 329

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A330">Analyse 330

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                      |                      |                                       |         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                                       |         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                                       |         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                                       |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                                       |         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A331">Analyse 331

                                                         +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A332">Analyse 332

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A333">Analyse 333

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
                                                         |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                       |                         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A334">Analyse 334

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A335">Analyse 335

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A336">Analyse 336

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A337">Analyse 337

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A338">Analyse 338

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A339">Analyse 339

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A340">Analyse 340

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A341">Analyse 341

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A342">Analyse 342

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                       |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                |                       |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A343">Analyse 343

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A344">Analyse 344

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A345">Analyse 345

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                             |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                             |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                             |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A346">Analyse 346

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                             |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A347">Analyse 347

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A348">Analyse 348

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A349">Analyse 349

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +----------------------COMP:V_PASS-N(with)---------------------+               |                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+                       |               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A350">Analyse 350

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A351">Analyse 351

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A352">Analyse 352

                                                                                                                                                                                                                                                                 +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A353">Analyse 353

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A354">Analyse 354

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |                                             +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A355">Analyse 355

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                                              +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    |   +------MOD_ATT:N-N------+               |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    |   |            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,FMK)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A356">Analyse 356

                                                                                                                        +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+                                                      
                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                        |                                                      
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                        |                                                      
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                        |                                                      
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                        |          +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A357">Analyse 357

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A358">Analyse 358

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +-------MOD_ATT:N-ADJ-------+               |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A359">Analyse 359

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                       |                         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +-------MOD_ATT:N-ADJ-------+               |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A360">Analyse 360

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                         +--------------------------------OBJ:V-N--------------------------------+         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  +----------------------------COMP:V-N(with)----------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  |      |                      +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            +---MOD_ATT:N-ADJ--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A361">Analyse 361

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +---MOD_ATT:N-ADJ--+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A362">Analyse 362

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      |                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A363">Analyse 363

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A364">Analyse 364

                                                                                                                                                +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A365">Analyse 365

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      +----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |                     +----MOD_ATT:N-N---+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A366">Analyse 366

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                       +-----------------------------------------COMP:V-N(with)-----------------------------------------+                                                                                                                          
           |                      |                      |                       |                         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                       |                         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |                       |                         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__SP__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A367">Analyse 367

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                     +----------------------------------COMP:V-N(In)----------------------------------+                                                                                                                          
           |                                                                                     |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                     |         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(In) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A368">Analyse 368

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A369">Analyse 369

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A370">Analyse 370

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A371">Analyse 371

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                                                 |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |                             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A372">Analyse 372

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A373">Analyse 373

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A374">Analyse 374

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A375">Analyse 375

                                                                                                                                                +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A376">Analyse 376

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A377">Analyse 377

                                                                                                                                                +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A378">Analyse 378

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |                     +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |                                    |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A379">Analyse 379

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                                                                               |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |                                +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+                                    |    +MOD+                       |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |                                    |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A380">Analyse 380

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           +------------------------------------COMP:N-N(with)-----------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           +----------------COMP:N-N(with)---------------+            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+                      |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,protein)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A381">Analyse 381

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+----COMP:V-N(with)----+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,protein)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A382">Analyse 382

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +-------MOD_ATT:N-ADJ-------+------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (__SP__,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A383">Analyse 383

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A384">Analyse 384

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                               |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                               |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A385">Analyse 385

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                                       +---------------------------------COMP:V-N(with)---------------------------------+                                                                                                                          
           |                      |                      |                                       |         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                                       |         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |                      |            +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |                      |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,protein)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A386">Analyse 386

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A387">Analyse 387

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A388">Analyse 388

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A389">Analyse 389

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      +-------------------------------COMP:V-N(In)-------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A390">Analyse 390

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
                  +--------------------------------COMP:V-N(with)--------------------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                  |                                                   +--------MOD_ATT:N-N-------+         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A391">Analyse 391

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |                                         +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A392">Analyse 392

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |                                         +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A393">Analyse 393

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |                                         +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A394">Analyse 394

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
                                                         |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
                                                         |            |                                    |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A395">Analyse 395

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |                                             |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A396">Analyse 396

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
                                                         +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
                                                         |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A397">Analyse 397

                                                         +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
                                                         |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
                                                         |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
                                                         |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
                                                         |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
                                                         |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
                                                         |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
                                                +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A398">Analyse 398

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A399">Analyse 399

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A400">Analyse 400

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A401">Analyse 401

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                                             |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |            |                                    |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A402">Analyse 402

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A403">Analyse 403

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A404">Analyse 404

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A405">Analyse 405

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
                                                                                                                        |       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
                                                                                                                        |       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A406">Analyse 406

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |      +----------------COMP:V_PASS-N(with)----------------+                          |         |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A407">Analyse 407

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A408">Analyse 408

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                                    |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A409">Analyse 409

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A410">Analyse 410

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A411">Analyse 411

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      |                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A412">Analyse 412

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      +--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A413">Analyse 413

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |                       +------------COMP:V-N(with)------------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            +MOD_ATT:N-+       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__SP__,overproduce)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A414">Analyse 414

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                                                                                               |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                                                                                               |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                                                                                               |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A415">Analyse 415

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |                  +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |                  |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A416">Analyse 416

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |                  +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |                  |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A417">Analyse 417

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+                  +MOD+            |                  +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |                  |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A418">Analyse 418

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A419">Analyse 419

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |             +--------------------------------OBJ:V-N--------------------------------+         +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A420">Analyse 420

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A421">Analyse 421

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A422">Analyse 422

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A423">Analyse 423

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A424">Analyse 424

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A425">Analyse 425

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |                      |                      +------------------------COMP:V-N(with)------------------------+       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+       |      |        |        +------------MOD_ATT:N-N------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A426">Analyse 426

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A427">Analyse 427

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                      |                      |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A428">Analyse 428

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                      |                      |                               |                 +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |                               |                 |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |                               |                 |      |     |       |      +-----------MOD_ATT:N-N-----------+        |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+       |         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A429">Analyse 429

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |                      |                      |            |                                    |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A430">Analyse 430

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                  +--MOD_ATT:N-ADJ-+--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A431">Analyse 431

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A432">Analyse 432

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A433">Analyse 433

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-----------------------------------COMP:V-N(In)-----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |                                             +---------COMP:V-N(with)--------+       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            +--COMP:V-N(with)--+       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          +SUBJ:V-+OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
COMP:V-N(with) (__NODE__,FMK)
COMP:V-N(with) (__NODE__,overproduce)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A434">Analyse 434

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A435">Analyse 435

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                  +--MOD_ATT:N-ADJ-+          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A436">Analyse 436

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                                             +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A437">Analyse 437

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A438">Analyse 438

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A439">Analyse 439

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                +----------------------------COMP:N-N(of)----------------------------+                                  +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                                +------------COMP:N-N(in)-----------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +-------------OBJ:V-N------------+         +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |              +---MOD_ATT:N-N---+         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+              |        +MOD_ATT:+         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |              |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,antibody)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:N-N(in) (antibody,activation)
COMP:N-N(of) (antibody,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A440">Analyse 440

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |      +----------------COMP:V_PASS-N(with)----------------+                          |                      |                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      +----------COMP:V_PASS-N(with)---------+            |                          |                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      |      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A441">Analyse 441

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                                             |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |            |                                    |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A442">Analyse 442

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                                                                               +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A443">Analyse 443

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A444">Analyse 444

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A445">Analyse 445

      +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                                                                                                                                   
      |    +-----------------------------------SUBJ:V-N----------------------------------+       +---------------------APPOS--------------------+                                                                                                                                                            
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |      |                             +-------------OBJ:V-N------------+       |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      |                             |    +--MOD_ATT:N-ADJ-+          |       |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A446">Analyse 446

      +-------------------------------COMP:V-N(In)-------------------------------+               +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-------------------------------SUBJ:V-N------------------------------+               |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +----------------------COMP:N-N(with)----------------------+          |               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+            |          |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |            |          +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
COMP:N-N(with) (cell,overproduce)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A447">Analyse 447

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                                             +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A448">Analyse 448

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                                             |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |            |                                    |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A449">Analyse 449

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                                             +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                                             |                               +-------------------------------------COMP:V-N(with)-------------------------------------+                                                                                                                          
           |                                             |                               |                 +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |                                             |                               |                 |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |                                    +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           +----COMP:N-N(with)----+             |        |            +----MOD_ATT:N-N---+       |         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,cycloheximide)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,__NODE__)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A450">Analyse 450

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |                      |                                +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+             |                      |    +MOD+                       |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |             |                      |    |   |                       |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A451">Analyse 451

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A452">Analyse 452

      +-----------------------------------COMP:V-N(In)-----------------------------------+       +---------------------APPOS--------------------+                                                                                                                                                            
      |    +-----------------------------------SUBJ:V-N----------------------------------+       |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    |      +----------------COMP:V_PASS-N(with)----------------+                  |       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |                  |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    |      |                             +-------------OBJ:V-N------------+       |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A453">Analyse 453

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                        +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |                      |                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A454">Analyse 454

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A455">Analyse 455

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |      +--------------------------COMP:V_PASS-N(with)-------------------------+       |                      |                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |      |      |                      +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |      +----------COMP:V_PASS-N(with)---------+            +----MOD_ATT:N-N---+       |                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,__NODE__)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A456">Analyse 456

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                       +---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
           |                      |                      +------------------------COMP:V-N(with)------------------------+                       +----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A457">Analyse 457

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A458">Analyse 458

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A459">Analyse 459

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A460">Analyse 460

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |                      |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |                      |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |                      |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |                      |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+               |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A461">Analyse 461

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
      +-------------------------------COMP:V-N(In)-------------------------------+               |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
      |    +-------------------------------SUBJ:V-N------------------------------+               |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
      |    +----------------COMP:N-N(with)---------------+                       |               |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      |    +----COMP:N-N(with)----+                      |                       +----OBJ:V-N----+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+               |                  +MOD+            +-SUBJ:V-N-+       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |                  |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:N-N(with) (cell,cycloheximide)
COMP:N-N(with) (cell,FMK)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-ADJ (FMK,zVAD)
COMP:V-N(In) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A462">Analyse 462

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                  +-------------------COMP:V-N(with)------------------+                          |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
                  |                             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
                  +------------COMP:V-N(with)------------+            |                          |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A463">Analyse 463

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                  +-------------------COMP:V-N(with)------------------+                          |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  |                             +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  +------------COMP:V-N(with)------------+            |                          |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+                             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A464">Analyse 464

                                                                                                 +---------------------APPOS--------------------+                                                                                                                                                            
                                                                                                 |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  +-------------------COMP:V-N(with)------------------+                          |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  |                             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                +-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+------------COMP:V-N(with)------------+            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |               |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A465">Analyse 465

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 +---------------------------COMP:V-N(with)--------------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:V-N(with) (increase,promoter)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A466">Analyse 466

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A467">Analyse 467

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+----------------------------COMP:V-N(in)----------------------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(in) (__SP__,activation)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A468">Analyse 468

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+--------------------------------------------------------COMP:V-N(with)-------------------------------------------------------+          +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                        |          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
COMP:V-N(with) (__SP__,promoter)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A469">Analyse 469

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------------------MOD_ATT:N-N-------------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      +----------------------MOD_ATT:N-N---------------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     +------------------MOD_ATT:N-ADJ-----------------+        |                                                                                                                          
           |                      |                      |            |                                    |      |     |       +---------------MOD_ATT:N-N--------------+        |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      |     |       |      +-----------MOD_ATT:N-N-----------+        |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     |       |      |        +-------MOD_ATT:N-N------+        |          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       |      |        |        +--MOD_ATT:N-N--+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      |        |        |         +MOD_A+SUBJ:V-N+--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (culture,agonist)
MOD_ATT:N-N (culture,anti)
MOD_ATT:N-ADJ (culture,__SP__)
MOD_ATT:N-N (culture,1)
MOD_ATT:N-N (culture,[__NODE__])
MOD_ATT:N-N (culture,protein)
MOD_ATT:N-N (culture,antibody)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,culture)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A470">Analyse 470

                                                                                                                        +-------------------------------OBJ:V-N------------------------------+                                                                                                               
           +------------------------------------------------COMP:V-N(In)------------------------------------------------+       +-------------------------MOD_ATT:N-N------------------------+                                                                                                               
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+       |      +---------------------MOD_ATT:N-N---------------------+                                                                                                               
           |             +--------------------------------OBJ:V-N--------------------------------+                      |       |      |        +-----------------MOD_ATT:N-N----------------+                                                                   +----------------OBJ:V-N----------------+   
           |             |        |                      +------------------------COMP:V-N(with)------------------------+       |      |        |        +------------MOD_ATT:N-N------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      |       |      |        |        |         +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            +----MOD_ATT:N-N---+--------COMP:V-N(with)--------+       |      |        |        |         |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          +MOD_ATT+       |         +MOD_AT+SUBJ:+       |      |        |        |         |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |        |         |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-N (__NODE__,overproduce)
MOD_ATT:N-ADJ (__NODE__,__SP__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,__NODE__)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,activation)
MOD_ATT:N-N (activation,1)
MOD_ATT:N-N (activation,[__NODE__])
MOD_ATT:N-N (activation,protein)
MOD_ATT:N-N (activation,antibody)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A471">Analyse 471

                         +--------------------------------OBJ:V-N--------------------------------+---------------------APPOS--------------------+                                                                                                                                                            
                  +-------------------COMP:V-N(with)------------------+                          |         +-------------MOD_ATT:N-N------------+---------------------------------COMP:N-N(of)--------------------------------+                                  +----------------OBJ:V-N----------------+   
                  |      |                      +---------------------OBJ:V-N--------------------+         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+                                |                                  |        +---------MOD_ATT:N-ADJ--------+   
                  +------------COMP:V-N(with)------------+            |                          |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+                                |                                  |        |       +------MOD_ATT:N-N-----+   
      +COMP:V-N(In+      |                      |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+-COMP:V-N(with)+             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
COMP:V-N(In) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,cycloheximide)
COMP:V-N(with) (treat,FMK)
COMP:V-N(with) (treat,overproduce)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
COMP:N-N(of) (protein,gene)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A472">Analyse 472

      +-----------------------------------COMP:V-N(In)-----------------------------------+                                                                                                                                                                                                                   
      |    +-----------------------------------SUBJ:V-N----------------------------------+                                                                                                                                                                                                                   
      |    |             +------------------------OBJ:V-N------------------------+       |       +---------------------APPOS--------------------+                                                                                                                                                            
      |    |      +----------------COMP:V_PASS-N(with)----------------+          |       |       |         +-------------MOD_ATT:N-N------------+                                                                                                                +----------------OBJ:V-N----------------+   
      |    |      +----------COMP:V_PASS-N(with)---------+            |          |       |       |         |      +---------MOD_ATT:N-N---------+----------------COMP:N-N(in)----------------+---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
      |    |      |      |                      +-------------OBJ:V-N------------+       |       |         |      |     +-----MOD_ATT:N-ADJ-----+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
      |    |      |      |                      |    +--MOD_ATT:N-ADJ-+          |       |       |         |      |     |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      |    +SUBJ:V+COMP:V_PASS-N(w+             |    +MOD+            |          |       +OBJ:V-N+         |      |     |       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,cycloheximide)
COMP:V_PASS-N(with) (treat,FMK)
COMP:V_PASS-N(with) (treat,overproduce)
OBJ:V-N (with,__SP__)
OBJ:V-N (with,__SP__)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
COMP:V-N(In) (__NODE__,Hela)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)
APPOS (protein,protein)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A473">Analyse 473

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |                                                                              |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+-------------SUBJ:V-N-------------+        |       +------MOD_ATT:N-N-----+   
           |             |        |             |    +--MOD_ATT:N-ADJ-+          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+          |        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (overproduce,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,gene)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A474">Analyse 474

           +------------------------------------------------COMP:V-N(In)------------------------------------------------+                                                                                                                                                                                    
           |                      +------------------------------------COMP:V-N(with)-----------------------------------+                                                                                                                                                                                    
           |             +--------------------------------OBJ:V-N--------------------------------+                      |                                                                                                                                                                                    
           |             |        |                      +------------------------COMP:V-N(with)------------------------+                                                                                                                                        +----------------OBJ:V-N----------------+   
           |             |        |                      |            +------------------COMP:V-N(with)-----------------+                       +----------------COMP:N-N(in)----------------+                                                                   |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+                      +--------OBJ:V-N--------+                  +-------MOD_ATT:N-N-------+----------COMP:N-N(of)----------+                                  |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+                      |       +--MOD_ATT:N-N--+                  |     +----MOD_ATT:N-N----+               +---MOD_ATT:N-N--+-----COMP:N-N(with)----+          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         +MOD_AT+SUBJ:+       |      +MOD_ATT:+                  |     |        +MOD_ATT:N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(In) (__SP__,cell)
COMP:V-N(with) (__SP__,cycloheximide)
COMP:V-N(with) (__SP__,FMK)
COMP:V-N(with) (__SP__,overproduce)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,activation)
MOD_ATT:N-N (activation,cell)
MOD_ATT:N-N (activation,culture)
MOD_ATT:N-N (activation,increase)
COMP:N-N(of) (activation,gene)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
COMP:N-N(with) (gene,promoter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)

name="reponse" value="A475">Analyse 475

           +-----------------------------------------------------------------------------COMP:V-N(In)-----------------------------------------------------------------------------+                                                                                                                          
           |                      +-----------------------------------------------------------------COMP:V-N(with)----------------------------------------------------------------+                                                                                                                          
           |                      |                      +-----------------------------------------------------COMP:V-N(with)-----------------------------------------------------+                                                                                                                          
           |                      |                      |            +-----------------------------------------------COMP:V-N(with)----------------------------------------------+                                                                                                                          
           |                      |                      |            |                                    +-------------MOD_ATT:N-N------------+                                 |                                                                              +----------------OBJ:V-N----------------+   
           |             +--------------------------------OBJ:V-N--------------------------------+         |      +---------MOD_ATT:N-N---------+                                 |          +---------------------COMP:N-N(with)---------------------+          |        +---------MOD_ATT:N-ADJ--------+   
           |             |        |             +---------------------OBJ:V-N--------------------+         |      |     +-----MOD_ATT:N-ADJ-----+-------------SUBJ:V-N------------+          +----------COMP:N-N(of)----------+                       |          |        |       +------MOD_ATT:N-N-----+   
           |             |        |             |        |            |          +-MOD_ATT:N-ADJ-+         |      |     |       +--MOD_ATT:N-N--+------COMP:N-N(in)------+        |          |               +---MOD_ATT:N-N--+                       |          |        |       |       +--MOD_ATT:N-N-+   
      +MOD_+SUBJ:V+      |        |             |    +MOD+            |          |       +MOD_ATT+         |      |     |       |      +MOD_ATT:+                  +MOD_A+        +--OBJ:V-N-+               |         +MOD_AT+             +MOD_ATT:N+-SUBJ:V-N-+        |       |       |       +MOD_AT+   
      |    |      |      |        |             |    |   |            |          |       |       |         |      |     |       |      |        |                  |     |        |          |               |         |      |             |         |          |        |       |       |       |      |   
 In Hela cells treated with cycloheximide and with zVAD FMK and overproducing __SP__ __NODE__ protein , agonist anti __SP__ Apo 1 [__NODE__] protein antibody in cell culture increases activation of a luciferase reporter gene with a synthetic promoter that has a __NODE__ protein protein binding site .
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,protein)
OBJ:V-N (with,protein)
MOD_ATT:N-ADJ (FMK,zVAD)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
MOD_ATT:N-N (protein,agonist)
MOD_ATT:N-N (protein,anti)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
COMP:N-N(in) (protein,culture)
MOD_ATT:N-N (culture,cell)
COMP:V-N(In) (increase,cell)
COMP:V-N(with) (increase,cycloheximide)
COMP:V-N(with) (increase,FMK)
COMP:V-N(with) (increase,overproduce)
SUBJ:V-N (increase,protein)
OBJ:V-N (increase,activation)
COMP:N-N(of) (activation,gene)
COMP:N-N(with) (activation,promoter)
MOD_ATT:N-N (gene,luciferase)
MOD_ATT:N-N (gene,reporter)
MOD_ATT:N-ADJ (promoter,synthetic)
SUBJ:V-N (have,promoter)
OBJ:V-N (have,site)
MOD_ATT:N-ADJ (site,__NODE__)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,protein)
MOD_ATT:N-N (site,binding)